Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease

Parkinson disease (PD) is a neurodegenerative disease mainly characterized by the loss of nigral dopaminergic neurons in the substantia nigra pars compacta. Patients suffering from PD develop severe motor dysfunctions and a myriad of non-motor symptoms. The treatment mainly consists of increasing ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Holanda, Victor A. D., Didonet, Julia J., Costa, Manara B. B., do Nascimento Rangel, Adriano H., da Silva, Edilson D., Gavioli, Elaine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401573/
https://www.ncbi.nlm.nih.gov/pubmed/34451872
http://dx.doi.org/10.3390/ph14080775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401573/
https://www.ncbi.nlm.nih.gov/pubmed/34451872
http://dx.doi.org/10.3390/ph14080775

Ejemplares similares